Breast Cancer Clinical Trials

Completed

Polyamine-free Diet to Prevent Post Surgery Hyperalgesia

NCT00304850

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations: CLCC-Institut Bergonie, service d'anesthésie réanimation, 229 cours de l'Argonne Bordeaux, France

département d'anesthésie-réanimation 3, hôpital Pellegrin Bordeaux, France

CLCC Alexis Vautrin Nancy, France

APHParis Hôpital Pitié Salpétrière - Dépt. d'anesthésie réanimation Paris, France

View Trial Details

Completed

A Phase III Trial For Patients With Metastatic Breast Cancer

NCT00191152

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Glendale, Arizona, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Fort Smith, Arkansas, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Hot Springs, Arkansas, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States

View all 65 locations

View Trial Details

Completed

Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

NCT00580086

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Comparative Study of Oestradiol Suppression: Zoladex 10.8mg/3 Month vs. 3.6mg/Month in ER +ve EBC Pre-menopausal Patients

NCT00303524

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Research Site Chiba, Japan

Research Site Fukuoka, Japan

Research Site Fukushima, Japan

Research Site Isehara, Japan

View all 22 locations

View Trial Details

Completed

A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients

NCT00190671

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Salzburg, Austria

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Vienna, Austria

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wels, Austria

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Brno, Czechia

View all 13 locations

View Trial Details

Completed

A Study of Gemcitabine and Carboplatin (Plus Herceptin in Human Epidermal Growth Factor Receptor 2 Positive [HER2+] Patients) With Metastatic Breast Cancer

NCT00191451

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States

View Trial Details

Completed

Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole

NCT00237224

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Novartis Investigative Site Guadalajara, Zacatecas, México DF, Mexico

View Trial Details

Completed

Anastrozole Reduced Proliferation and Progesterone Receptor Indexes in Short Term Hormone Therapy

NCT01016665

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: Sao Paulo Federal University São Paulo, Brazil

View Trial Details

Completed

Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers

NCT00608452

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +41 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy for Metastatic Breast Cancer

NCT00191815

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician Munich, Germany

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician Moscow, Russia

View Trial Details

Breast Cancer

Breast Cancer trial results

Related conditions